Global Psoriasis
Therapeutics Market 2015-2019 is the latest addition
to Sandlerresearch.org industry research reports collection.
Psoriasis is a common immune-mediated disease of the skin. In psoriasis,
the skin grows fast and causes buildup of thick white, red, or silvery patches
of skin. It alters the normal cell cycle of the skin. The new cells of the skin
grow and move quickly to the surface of the skin to form patches known as
“plaques”. The plaques are commonly found on knees, elbows, scalp, hands, and
feet. Psoriasis occurs mostly in adults, but can also be seen in children and
adolescents. The etiology of the disease is unknown, however, it is believed to
be an immune-mediated process. It is believed that the over-activity of the
immune system can cause inflammation, thereby resulting in flaking of the skin.
Analysts forecast the Global Psoriasis
Therapeutics market to grow at a CAGR
of 9.95 percent over the period 2014-2019.
Covered in this
Report
This report covers the present scenario and the growth prospects of the
Global Psoriasis Therapeutics market for the period 2015-2019. To calculate the
market size, the report considers revenue generated from the sales of various
drugs including systemic and topical drugs used in the treatment of:
- Psoriasis
- Psoriatic Arthritis
The Global Psoriasis Therapeutics market is segmented based on the
mechanism of action of the drugs used
to treat psoriasis and psoriatic
arthritis as illustrated below:
- TNF Inhibitors
- PDE4 Inhibitors
- Interleukin Blockers
- Others
The Global Psoriasis Therapeutics market is also segmented based on the
type of molecule used for the treatment of psoriasis, as illustrated below:
- Biologics
- Small Molecules
On the basis of route of administration adopted for the treatment of
psoriasis, the Global Psoriasis Therapeutics market is segmented as follows:
- Oral
- Parenteral
- Topical
The report also presents the vendor landscape and a corresponding
detailed analysis of the top four vendors in the Global Psoriasis Therapeutics
market. The vendor landscape section includes a market share analysis of the
major vendors along with the competitive performances of their product
portfolios. In addition, it discusses the major drivers that influence the
growth of the market. It also outlines the challenges faced by the vendors and
the market at large, as well as the key trends that are emerging in the market.
In addition, late-stage pipeline molecules developed for the treatment of
psoriasis have been discussed.
According to the report, growing unmet needs in terms of the
availability of appropriate drugs is one of the major factors propelling
the growth of the market. Current treatment options cannot cure the
disease completely, and the drugs have a low safety profile. Therefore,
drugs with a high safety profile that can cause remission of the disease
in patients will boost the growth of the market.
Global Psoriasis Therapeutics Market 2015-2019, has been prepared based
on an in-depth market analysis with inputs from industry experts. The report
covers the Americas, the APAC and the EMEA regions; it also covers the Global
Psoriasis Therapeutics market landscape and its growth prospects in the coming
years. The report also includes a discussion of the key vendors operating in
this market.
Single User License of the Report is Available
at USD 3000, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=29372 .
